Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurocrine Biosciences Inc Insider Profile
11 Followers
Neurocrine Biosciences Inc, Director at Neurocrine, holds 8.58M shares in Voyager Therapeutics (Ticker: VYGR), holds 16.03K shares in Neurocrine (Ticker: NBIX). Most recently, Neurocrine Biosciences Inc Bought ― shares of Voyager Therapeutics on Feb 24, 2023 for an estimated value of 39.03M.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-20.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Neurocrine Biosciences Inc holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 24, 2023 - Feb 24, 2024
Return:+15.30%
The most profitable trade made by Neurocrine Biosciences Inc
Neurocrine Biosciences Inc's Trading History
Neurocrine
Apr 09, 2015
Director
Uninformative Sell
71.40K
$2.18M
Voyager Therapeutics
Feb 24, 2023
Ten Percent Owner
Informative Buy
39.03M
$72.72M
List of latest transactions for each holding click on a transaction to see Neurocrine Biosciences Inc's performance on stock
You May Also Like
Neurocrine Biosciences Inc insider profile FAQ
What is the percentage of profitable transactions made by Neurocrine Biosciences Inc?
The percentage of profitable transactions made by Neurocrine Biosciences Inc is 50%.
What is the average return per transaction made by Neurocrine Biosciences Inc?
The average return per transaction made by Neurocrine Biosciences Inc is -20.80%.
What stocks does Neurocrine Biosciences Inc hold?
Neurocrine Biosciences Inc holds: NBIX, VYGR stocks.
What was Neurocrine Biosciences Inc’s latest transaction?
Neurocrine Biosciences Inc latest transaction was an Informative Buy of $39.03M.
What was Neurocrine Biosciences Inc's most profitable transaction?
Neurocrine Biosciences Inc’s most profitable transaction was an Informative Buy of VYGR stock on February 24, 2023. The return on the trade was 15.30%.
What is Neurocrine Biosciences Inc's role in Neurocrine?
Neurocrine Biosciences Inc's role in Neurocrine is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.